These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25588366)

  • 41. Mechanistic investigation of food effect on disintegration and dissolution of BCS class III compound solid formulations: the importance of viscosity.
    Radwan A; Amidon GL; Langguth P
    Biopharm Drug Dispos; 2012 Oct; 33(7):403-16. PubMed ID: 22782559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen.
    Shohin IE; Kulinich JI; Ramenskaya GV; Abrahamsson B; Kopp S; Langguth P; Polli JE; Shah VP; Groot DW; Barends DM; Dressman JB
    J Pharm Sci; 2012 Oct; 101(10):3593-603. PubMed ID: 22786667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterising Drug Release from Immediate-Release Formulations of a Poorly Soluble Compound, Basmisanil, Through Absorption Modelling and Dissolution Testing.
    Stillhart C; Parrott NJ; Lindenberg M; Chalus P; Bentley D; Szepes A
    AAPS J; 2017 May; 19(3):827-836. PubMed ID: 28236228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melts of Octaacetyl Sucrose as Oral-Modified Release Dosage Forms for Delivery of Poorly Soluble Compound in Stable Amorphous Form.
    Haznar-Garbacz D; Kaminska E; Zakowiecki D; Lachmann M; Kaminski K; Garbacz G; Dorożyński P; Kulinowski P
    AAPS PharmSciTech; 2018 Feb; 19(2):951-960. PubMed ID: 29098644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biowaiver monographs for immediate-release solid oral dosage forms: stavudine.
    Silva AL; Cristofoletti R; Storpirtis S; Sousa VD; Junginger HE; Shah VP; Stavchansky S; Dressman JB; Barends DM
    J Pharm Sci; 2012 Jan; 101(1):10-6. PubMed ID: 21922462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs.
    Nkansah P; Antipas A; Lu Y; Varma M; Rotter C; Rago B; El-Kattan A; Taylor G; Rubio M; Litchfield J
    J Control Release; 2013 Jul; 169(1-2):150-61. PubMed ID: 23570985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of amorphization methods on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Paluch KJ; Tajber L; Grembecka M; Hawelek L; Wojnarowska Z; Grzybowska K; Talik E; Paluch M
    Eur J Pharm Sci; 2014 Oct; 62():132-40. PubMed ID: 24907679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations.
    Law D; Schmitt EA; Marsh KC; Everitt EA; Wang W; Fort JJ; Krill SL; Qiu Y
    J Pharm Sci; 2004 Mar; 93(3):563-70. PubMed ID: 14762895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of the in vivo performance of enteric coated pellets in the fasted state under selected biorelevant dissolution conditions.
    Stefanič M; Vrečer F; Rizmal P; Mrhar A; Bogataj M
    Eur J Pharm Sci; 2014 Oct; 62():8-15. PubMed ID: 24844699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using oral ziprasidone effectively: the food effect and dose-response.
    Citrome L
    Adv Ther; 2009 Aug; 26(8):739-48. PubMed ID: 19669631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fast-dissolving microparticles fail to show improved oral bioavailability.
    Wong SM; Kellaway IW; Murdan S
    J Pharm Pharmacol; 2006 Oct; 58(10):1319-26. PubMed ID: 17034654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
    Widanapathirana L; Tale S; Reineke TM
    Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biowaiver monographs for immediate release solid oral dosage forms: efavirenz.
    Cristofoletti R; Nair A; Abrahamsson B; Groot DW; Kopp S; Langguth P; Polli JE; Shah VP; Dressman JB
    J Pharm Sci; 2013 Feb; 102(2):318-29. PubMed ID: 23175470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone.
    Lincoln J; Stewart ME; Preskorn SH
    J Psychiatr Pract; 2010 Mar; 16(2):103-14. PubMed ID: 20511734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicting the oral pharmacokinetic profiles of multiple-unit (pellet) dosage forms using a modeling and simulation approach coupled with biorelevant dissolution testing: case example diclofenac sodium.
    Kambayashi A; Blume H; Dressman JB
    Eur J Pharm Biopharm; 2014 Jul; 87(2):236-43. PubMed ID: 24462791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.
    Hecq J; Deleers M; Fanara D; Vranckx H; Boulanger P; Le Lamer S; Amighi K
    Eur J Pharm Biopharm; 2006 Nov; 64(3):360-8. PubMed ID: 16846725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selection of a discriminant and biorelevant in vitro dissolution test for the development of fenofibrate self-emulsifying lipid-based formulations.
    Pestieau A; Krier F; Brouwers A; Streel B; Evrard B
    Eur J Pharm Sci; 2016 Sep; 92():212-9. PubMed ID: 27169683
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
    Kortejärvi H; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.